Comparison of calculated and direct low density lipoprotein cholesterol determinations in a routine laboratory

East African Medical Journal

Volumn 81, Issue 3, 2004, Pages 154-158

  Amayo, A A ^a   Kirera, S ^b  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b Mater Hospital   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD; BLOOD ANALYSIS; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EVALUATION; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; BLOOD CHEMICAL ANALYSIS; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 4444270957     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: 10.4314/eamj.v81i3.9146     Document Type: Article

References (24)

1. Gordon, T., Kannel, W.B., Castelli, W.P., and Dawber, T.R. Lipoproteins cardiovascular disease and death. The Framingham study. Arch. Intern. Med. 1981; 141:1128-1131.
2. Grundy, S.M. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin. Chem. 1995; 41:139-146.
3. Kannel, W.B., Nekton, J.D., Wentworth, D., et al., for the MRFIT Research Group. Overall and coronary heart disease mortality rates in relation to major risk factors in 325;348 men screened for the Multiple Risk Factor Intervention Trial MRFIT. Amer. Heart J. 1986; 112:825-836.
4. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J. Amer. Med. Assoc. 1984; 251:365-374.
5. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4,444 patient with coronary heart disease. The Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344:1383-1389.
6. Sacks, P.M., Pfeffer, M.A., Moye, L.A., Rouleau, J.L. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Engl. J. Med. 1996; 335:14:1001-1009.
7. DeLong, D.M., Delong, E.R., Wood, P.D., Lippel, K., and Rifkind, B.M. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol: the lipid research clinics prevalence study. J. Amer. Med. Assoc. 1986; 256:2372-2377.
8. Bachorik, P.S. and Ross, J.W. National cholesterol education program recommendations for measurement of low density lipoprotein cholesterol: executive summary. Clin. Chem. 1995; 41:1414-1420.
9. Friedewald, W.T., Levy, R.I., and Fredrickson, D.S. Estimation of concentration of low-density lipoprotein cholesterol in plasma without use ofthe ultracentrifuge. Clin. Chem. 1972; 38:150-160.
10. Rifai, N., Warnick, G.R., McNamara, J.R., Belcher, J.D., Grinstead, J.F., and Frantz, I.D. Measurement of low-density-lipoprotein cholesterol in serum: a status report (Review). Clin. Chem. 1992; 38:150-160.
11. McNamara, J.R., Cohn, J.S., Wilson, P.W.F., and Schaefer, E.J. Calculated values for low-density lipoprotein in the assessment of lipid abnormalities and coronary disease risk. Clin. Chem. 1990; 36:36-42.
12. Matas, C., Cabre, M., La Vilie, A., et al. Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease. Clin. Chem. 1994; 40:404-406.
13. Maitra, A., Hirany, S.V. and Jialal, I. Comparison of two assays for measuring LDL cholesterol. Clin. Chem. 1997; 43; 6:1040-1047.
14. Esteban-Salan, M., Guimon-Bardesi, A., Viuda-Unzueta, J.M., Azcarate-Ania, M.N., et al. Analytical and clinical evaluation of two homogeneous assays for LDL-cholesterol in Hyperlipidemic patients. Clin. Chem. 2000; 46:1121-1131.
15. Harris, N. Neufeld, E.J., Newburger, J.W., Ticho, B. and Baker, A. Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidaemic pediatric population. Clin. Chem. 1996; 42:1182-1188.
16. Schectman, G., Patsches, M., and Sasse, E.A. Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations. Clin. Chem. 1996; 42: 732-737.
17. Krause, B.R., Schork, N.J., Kieft, K.A., Smith, M.P. et al. High correlation but lack of agreement between direct high-performance gel chromatography analysis and conventional indirect methods for determining lipoprotein cholesterol. Clin. Chem. 1996; 42:1996-2001.
18. Bland, J.M., and Altman, D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1:307-310.
19. Yonga, G.O., Ogola E.N. and Juma F.D. Cardiovascular risk factor profiles in mild to moderate hypertensives at Kenyatta Hospital. East Afr. Med. J. 1993; 70:693.
20. Amoah, A.G.B. Spectrum of Cardiovascular disorders in a National referral centre, Ghana. East Afr. Med. J. 2000; 77:648-653.
21. Gebre-Yohannes, A. and Rahlenbeck, S.I. Coronary heart disease risk factors among blood donors in Northwest Ethiopia. East Afr. Med. J. 1998; 75:495-500.
22. Jialal, I.A. practical approach to the laboratory diagnosis of dyslipidemia. Amer J. Clin. Pathol. 1996; 106:128-138.
23. Rubies-Prat, J., Revere, R.J., Senti, M., Pedro-Botet, J. et al. Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus. Diabetes Care. 1993; 16:1081-1086.
24. Hirany, S.V., Li, D. and Jialal, I. A more valid measurement of LDL cholesterol in diabetic patients. Amer. J. Med. 1997; 102:48-53.